World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
9309
World Ranking
4070
National Ranking
357

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Emma Morris is affiliated with University College London in the United Kingdom. Their research activity is primarily situated in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. The subfields with a notable focus in their scholarly output include Immunology, Genetics, Oncology, Molecular Biology, and Infectious Diseases.

The main topics of their research encompass Immunodeficiency and Autoimmune Disorders, CAR-T cell therapy research, Hematopoietic Stem Cell Transplantation, Virus-based gene therapy research, Blood disorders and treatments, Immune Cell Function and Interaction, and COVID-19 Clinical Research Studies.

The following recent papers authored by or involving Emma Morris illustrate their research scope and impact:

  • Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy, 2021, Nature Reviews Immunology

Other frequently cited works coauthored by the scientist, although credited to other primary authors, form relevant context in related research areas:

  • Lentiviral gene therapy for X-linked chronic granulomatous disease, 2020, Nature Medicine
  • Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation, 2022, Nature Immunology
  • EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity, 2021, Bone Marrow Transplantation
  • Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome, 2022, Nature Medicine

Emma Morris has collaborated frequently with the following researchers:

  • Siobhan O. Burns
  • Thomas A. Fox
  • Claire Booth
  • Austen Worth
  • Despina Moshous

The most common venues for their publications include:

  • Blood
  • Journal of Clinical Immunology
  • British Journal of Haematology
  • Journal of Allergy and Clinical Immunology
  • Bone Marrow Transplantation

Emma Morris has been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom. This distinction reflects an acknowledgment by a professional body within the medical sciences community.

Best Publications

  • Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy

    Emma C. Morris;Sattva S. Neelapu;Theodoros Giavridis;Michel Sadelain

  • Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.

    Karl S Peggs;Ann Hunter;Rajesh Chopra;Anne Parker

  • Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

    Emma Morris;Kirsty Thomson;Kirsty Thomson;Charles Craddock;Charles Craddock;Prem Mahendra;Prem Mahendra

  • Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

    Karl S. Peggs;Kirsty Thomson;Daniel P. Hart;Johanne Geary

  • Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications.

    Emma C. Morris;Peppy Rebello;Kirsty J. Thomson;Karl S. Peggs

  • Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells.

    Shao-An Xue;Liquan Gao;Daniel Hart;Roopinder Gillmore

  • Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation

    Unknown

  • The evolution of cellular deficiency in GATA2 mutation

    Rachel E. Dickinson;Paul Milne;Laura Jardine;Sasan Zandi

  • Lentiviral gene therapy for X-linked chronic granulomatous disease.

    Donald B. Kohn;Claire Booth;Elizabeth M. Kang;Sung-Yun Pai

  • Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient

    Waseem Qasim;Maurizia Brunetto;Adam J. Gehring;Shao-An Xue

  • Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma

    Kirsty J Thomson;Emma C Morris;Adrian Bloor;Gordon Cook

  • T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma

    Kirsty J. Thomson;Emma C. Morris;Don Milligan;Anne N. Parker

  • Allogeneic Hematopoietic Stem Cell Transplantation and Norovirus Gastroenteritis: A Previously Unrecognized Cause of Morbidity

    C. Roddie;J. P.V. Paul;R. Benjamin;Christopher Gallimore

  • EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.

    A. C. Lankester;M. H. Albert;C. Booth;A. R. Gennery

  • Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell–Depleted Allogeneic Transplantation for Hodgkin's Lymphoma

    Karl S. Peggs;Irfan Kayani;Noha Edwards;Panagiotis Kottaridis

  • CD3 limits the efficacy of TCR gene therapy in vivo

    Maryam Ahmadi;Judith W. King;Shao An Xue;Cécile Voisine

  • A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection

    Emma C. Morris;Aristotle Tsallios;Gavin M. Bendle;Shao-an Xue

  • Distinctive patterns of memory function in subgroups of females with Turner syndrome: evidence for imprinted loci on the X-chromosome affecting neurodevelopment.

    D.V.M Bishop;E Canning;K Elgar;E Morris

  • Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

    Sharyn Thomas;Shao-An Xue;Charles R. M. Bangham;Bent K. Jakobsen

  • Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.

    Karl S. Peggs;Stephen Mackinnon;Catherine D. Williams;Shirley D'Sa

  • Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow Transplantation.

    Gordon Cook;Graeme M. Smith;Keiren Kirkland;Julia Lee

  • Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation.

    Kirsty J Thomson;Karl S Peggs;P Smith;James Cavet

Frequent Co-Authors

Hans J. Stauss
Hans J. Stauss University College London
Karl S. Peggs
Karl S. Peggs University College London
David C. Linch
David C. Linch University College London
Siobhan O. Burns
Siobhan O. Burns University College London
Adrian J. Thrasher
Adrian J. Thrasher University College London
Anthony H. Goldstone
Anthony H. Goldstone University College Hospital
Donald Milligan
Donald Milligan University of Birmingham
Charles Craddock
Charles Craddock Queen Elizabeth Hospital Birmingham
Matthew Collin
Matthew Collin Newcastle University
Mervyn Singer
Mervyn Singer University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees and career pathways can broaden professional opportunities. Many Immunology students consider advancing into healthcare roles such as nurse practitioners, which requires specialized training and certifications.

Transitioning roles within nursing, for example from a Family Nurse Practitioner (FNP) to acute care, is a common career progression. Achieving fnp to acute care certification can open doors to higher-level clinical responsibilities and increase job market competitiveness.

For newcomers to the field, accelerated nursing programs provide a fast-track route to gaining essential qualifications. There are excellent options listed under accelerated nurse practitioner programs that cater to those aiming for rapid advancement in nursing careers while balancing other commitments.

Additionally, career changers without a nursing background can explore tailored curricula through online nursing programs for non nurses. These programs build foundational skills essential for success in healthcare environments.

For prospective students seeking accessible options, the easiest accelerated nursing programs to get into offer flexible paths that remove traditional barriers, making the journey into nursing and related fields more attainable.

Best Scientists Citing Emma Morris

Trending Scientists

Recently Published Articles